News Highlights
Hetero's generic Paxlovid gets WHO pre-qualification
Hetero, on December 26, announced the receipt of World Health Organisation Prequalification (WHO PQ) for its generic version of COVID-19 oral anti-viral treatment candidate Nirmatrelvir. This medicine is recommended for high-risk patients.
The World Health Organization Living Guidelines
Contains the organization’s most up-to-date recommendations on drugs to prevent COVID-19, Therapeutics and Clinical management of COVID19. It is updated regularly as new evidence emerges.
WHO recommends two new drugs to treat COVID-19
WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.